Diuretics and Magnesium Depletion: What Furosemide and Thiazides Do
People on long-term diuretic therapy for heart failure, hypertension, or edema face a recognized risk of magnesium depletion that often goes unmonitored. Both loop diuretics and thiazide diuretics increase renal magnesium excretion — the kidneys eliminate more magnesium in the urine than they otherwise would. The effect is most pronounced with loop diuretics, but thiazides produce it too, and chronic use of either class can push magnesium levels low enough to cause symptoms. For people already taking other medications that deplete magnesium — proton pump inhibitors, for instance — the combination compounds the risk further.
Loop diuretics: the stronger effect
Furosemide (Lasix), bumetanide (Bumex), and torsemide (Demadex) act on the thick ascending limb of the loop of Henle, a section of the kidney tubule that normally reabsorbs a large fraction of filtered sodium, potassium, chloride, and magnesium before urine leaves the kidney. These drugs block the NKCC2 cotransporter — the protein that moves these ions from the tubule back into the bloodstream. Blocking it means more of everything reaches the urine, including magnesium.
The magnitude of magnesium wasting with loop diuretics is proportional to dose and duration of use. High-dose furosemide given for fluid overload in heart failure can produce significant hypomagnesemia — clinically low serum magnesium — within days. Chronic lower-dose therapy produces a more gradual depletion, which can be harder to attribute to the diuretic because the symptoms develop slowly. The NIH ODS Magnesium fact sheet identifies loop diuretics as a clinically significant cause of magnesium depletion.
Hypomagnesemia from loop diuretics matters beyond the numbers. Magnesium plays a central role in cardiac electrical activity, and low magnesium is associated with cardiac arrhythmias — a concern that is particularly relevant in the heart failure population that most commonly uses these drugs. Muscle cramps, weakness, and fatigue are other symptoms of depleted magnesium that may be incorrectly attributed to the underlying disease rather than the medication.
Thiazide diuretics: a real but less severe effect
Hydrochlorothiazide, chlorthalidone, and indapamide act on the distal convoluted tubule rather than the loop of Henle, targeting the NCC sodium-chloride cotransporter. Their primary effect is on sodium and water excretion. The increase in urinary magnesium excretion is less direct — reduced sodium reabsorption in this segment alters the electrochemical gradient that drives passive magnesium reabsorption — but it is real and accumulates over time with chronic use.
Thiazide-induced magnesium depletion is generally less severe than what loop diuretics produce, and is more commonly a concern with long-term daily use at higher doses. Many people tolerate chronic low-dose thiazide therapy without developing symptomatic hypomagnesemia. But in people who are already borderline deficient — due to diet, aging, type 2 diabetes (which is associated with magnesium wasting), or concurrent PPI use — thiazides can tip them into clinically significant depletion.
Compounding risks and monitoring
The combination of a diuretic with other magnesium-depleting medications is worth flagging explicitly. People on chronic PPI therapy who are also on furosemide face depletion pressure from two separate mechanisms simultaneously — NKCC2 inhibition increasing urinary magnesium loss, and impaired colonic TRPM6/TRPM7 transport reducing magnesium reabsorption from the gut. Neither is offset by the other. The 2011 FDA safety communication on PPI-associated hypomagnesemia specifically noted that risk is higher in people who are concurrently on diuretics.
Standard electrolyte panels ordered in clinical practice do not always include magnesium. Sodium, potassium, chloride, and bicarbonate appear automatically; magnesium typically requires a separate order. Someone on a long-term loop diuretic who develops unexplained muscle cramps, weakness, or arrhythmias may benefit from having magnesium specifically checked — it may not appear on recent labs even if labs were drawn recently.
Magnesium supplementation is one approach, and it is often recommended for people on chronic diuretic therapy. Whether it is sufficient depends on the degree of urinary wasting — in some individuals on high-dose loop diuretics, oral supplementation cannot keep pace with ongoing renal losses, and the underlying diuretic dose or regimen may need to be revisited.